FindTrial
Sign In

Effect of dexmedetomidine on blood glucose after cesarean section in pregnant women with diabetes

Effect of dexmedetomidine on blood glucose after cesarean section in pregnant women with diabetes

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100045935
Enrollment
Unknown
Registered
2021-04-29
Start date
2021-05-01
Completion date
Unknown
Last updated
2021-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes

Interventions

experimental group:dexmedetomidine
control group:No

Sponsors

The First Affiliated Hospital of University of Science And Technology Of China
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Gestational diabetes; 2. ASA III level; 3. Aged 20-40 years; 4. 37-42 weeks of pregnancy; 5. BMI<=35 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Contraindications for intraspinal anesthesia; 2 Twin pregnancies; 3. Test drug allergy; 4. Preoperative application of analgesic and sedative drugs; 5. The parturient cannot understand the scoring items of various scales; 6. Have a history of neurological and psychiatric diseases; 7. Severe heart, lung, liver, and kidney dysfunction.

Design outcomes

Primary

MeasureTime frame
Blood Glucose;—

Countries

china

Contacts

Public ContactPan Kunyun

The First Affiliated Hospital of University Of Science And Technology Of China

pankunyun@163.com+86 13637070412

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026